Page 16 - Grail Algorithm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Grail algorithm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Grail Algorithm Today - Breaking & Trending Today

Next chapter of FTC's battle with Illumina over bid to buy Grail to play out in San Diego


Print
A federal judge has agreed to Illumina’s request to hold an injunction hearing in San Diego rather than Washington, D.C., as the Federal Trade Commission moves to temporarily prevent the sequencing giant from acquiring cancer diagnostic firm Grail.
It’s the latest development in an ongoing feud between Illumina and the FTC. The FTC argues that the San Diego company’s $7.1 billion bid to buy Grail would prevent other companies from launching their own early detection cancer tests. Illumina denies that claim, adding that it has the expertise needed to help Grail get its diagnostic test ready for primetime. ....

United States , San Diego , Menlo Park , District Of Columbia , Rudolph Contreras , Bill Gates , Jeff Bezos , Drug Administration , Federal Trade Commission , Southern District , United States District Judge Rudolph Contreras , Bay Area , Liquid Biopsy , ஒன்றுபட்டது மாநிலங்களில் , சான் டியாகோ , மென்லோ பூங்கா , மாவட்டம் ஆஃப் கொலம்பியா , ருடால்ப் கொன்றேரேஸ் , ர சி து வாயில்கள் , கூட்டாட்சியின் வர்த்தகம் தரகு , தெற்கு மாவட்டம் , வளைகுடா பரப்பளவு , திரவ பயாப்ஸி ,

EU to examine Illumina's $7.1 billion acquisition of Grail on antitrust grounds


2 Min Read
FILE PHOTO: The offices of gene sequencing company Illumina Inc are shown in San Diego, California January 11, 2016. REUTERS/Mike Blake
BRUSSELS (Reuters) - EU antitrust regulators will examine Illumina Inc’s proposed $7.1 billion acquisition of cancer test maker Grail Inc, the European Commission said on Tuesday, following a request from six countries on competition concerns.
U.S. life sciences company Illumina announced last September that it would acquire Grail - which it previously owned before spinning it off as a separate business four years ago - by buying out investors including Amazon.com Inc founder Jeff Bezos. Illumina had remained the company’s largest shareholder. ....

Bruxelles Capitale , Foo Yun Chee , Jeff Bezos , Susan Fenton , Thomson Reuters Trust Principles , Grail Inc , Us Federal Trade Commission , Illumina Inc , European Commission , Foo Yun , Trade Commission , Thomson Reuters Trust , Anti Competitive Behavior , Banking Amp Investment Services Trbc Level 2 , Eu Institutions , Company News , European Union , Healthcare Trbc Level 1 , Antitrust Regulation , Biotechnology Amp Medical Research Trbc Level 4 , Mergers Acquisitions Takeovers , Pharmaceuticals Trbc Level 4 , Pharmaceuticals Trbc Level 3 , Pharmaceuticals Nec Trbc Level 5 , Corporate Market Regulation , United States ,